Home › Esophageal Adenocarcinoma › Minnesota › Saint Paul
Esophageal Adenocarcinoma clinical trials in Saint Paul, MN
3 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Saint Paul (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RecruitingPhase 2/3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Saint John's Hospital - Healtheast, Maplewood · 5 mi away
- and 1 more
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RecruitingPhase 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi away
- and 3 more
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Allina Health Cancer Institute, Saint Paul
Esophageal Adenocarcinoma trials in other cities
- New York City, NY18 studies
- Boston, MA13 studies
- Houston, TX12 studies
- Nashville, TN11 studies
- Arlington, VA11 studies
- Durham, NC10 studies
- Rochester, MN9 studies
- St. Louis, MO9 studies
- Baldwin Park, CA9 studies
- Jacksonville, FL9 studies
- Queens, NY9 studies
- Los Angeles, CA9 studies
Other studies in Saint Paul
- Non-Small Cell Lung Cancer19 studies
- Prostate Cancer13 studies
- Lung Cancer13 studies
- Breast Cancer12 studies
- Colorectal Cancer9 studies
- Ovarian Cancer8 studies
- Metastatic Cancer7 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Endometrial Cancer6 studies
- Bladder Cancer6 studies
- Melanoma6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.